Mostrar el registro sencillo del ítem

dc.contributor.authorMARTINEZ PILLADO, MODESTO 
dc.contributor.authorVarela Duran, Marina 
dc.contributor.authorSaid Criado, Ismael
dc.contributor.authorDíaz Parada, Pilar
dc.contributor.authorRodríguez Losada, María 
dc.contributor.authorMendoza Pintos, María
dc.date.accessioned2019-08-06T07:31:22Z
dc.date.available2019-08-06T07:31:22Z
dc.date.issued2019
dc.identifier.issn2214-2509
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/?term=Disseminated+tuberculosis+and+hemophagocytic+syndrome+although+TB+prophylaxis+in+patients+with+inflammatory+bowel+disease+treated+with+Infliximabes
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477117/es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/12282
dc.description.abstractPurpose: We present de case of a 27-year-old woman admitted to ICU after scheduled splenectomy to study her short course of fever, leukopenia and splenic space-occupying lesions and splenomegaly. She has been previously treated with Infliximab due to indeterminate colitis and completed correct tuberculosis prophylaxis. Materials and methods: We reviewed our case in our regional Electronic Health DataBase IANUS and compared it with other case reports in literature, found in PubMed, with keywords tuberculosis, inflammatory disease and hemophagocytic lymphohistiocytosis. Results: After splenectomy, she needed intensive care due to acute respiratory failure, alveolar-interstitial pulmonary infiltrates, right pleural effusion and fever. Bone marrow aspirate resulted in hemophagocytic lymphohistiocytosis. Only multidisciplinary management in ICU and combined treatment with chemotherapy for hemophagocytic syndrome and tuberculostatics achieved her curation. Conclusion: Tuberculosis must always be considered in the differential diagnosis of hemophagocytic lymphohistiocytosis and acute respiratory failure despite correct prior prophylaxises
dc.language.isoenges
dc.rightsAttribution-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/*
dc.subject.meshInflammatory Bowel Diseases*
dc.subject.meshPleural Effusion*
dc.subject.meshMycobacterium tuberculosis*
dc.subject.meshIsoniazid*
dc.subject.meshRespiratory Insufficiency*
dc.subject.meshSplenectomy*
dc.subject.meshLymphohistiocytosis, Hemophagocytic*
dc.subject.meshIncidence*
dc.titleDisseminated tuberculosis and hemophagocytic syndrome although TB prophylaxis in patients with inflammatory bowel disease treated with Infliximabes
dc.typeArtigoes
dc.rights.holderLos autoreses
dc.identifier.doi10.1016/j.idcr.2019.e00518
dc.identifier.pmid31024797
dc.journal.titleIDCaseses
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Dirección - Equipo directivoes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica Ourense-Pontevedra-Vigo (IBI)es
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Anestesioloxía e reanimaciónes
dc.page.initiale00518es
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2214250918301306?via%3Dihubes
dc.rights.accessRightsopenAccesses
dc.subject.decslinfohistiocitosis hemofagocítica*
dc.subject.decsenfermedad inflamatoria intestinal*
dc.subject.decsincidencia*
dc.subject.decsisoniacida*
dc.subject.decsderrame pleural*
dc.subject.decsesplenectomía*
dc.subject.decsinsuficiencia respiratoria*
dc.subject.decsMycobacterium tuberculosis*
dc.subject.keywordDisseminated tuberculosises
dc.subject.keywordTuberculosis diseminadaes
dc.typefidesNota Clínica (inclue Casos Clínico)es
dc.typesophosOtroses
dc.volume.number16es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NoDerivatives 4.0 Internacional